Page last updated: 2024-11-06

hydroxyproline and Diabetic Cardiomyopathies

hydroxyproline has been researched along with Diabetic Cardiomyopathies in 4 studies

Hydroxyproline: A hydroxylated form of the imino acid proline. A deficiency in ASCORBIC ACID can result in impaired hydroxyproline formation.
hydroxyproline : A proline derivative that is proline substituted by at least one hydroxy group.

Diabetic Cardiomyopathies: Diabetes complications in which VENTRICULAR REMODELING in the absence of CORONARY ATHEROSCLEROSIS and hypertension results in cardiac dysfunctions, typically LEFT VENTRICULAR DYSFUNCTION. The changes also result in myocardial hypertrophy, myocardial necrosis and fibrosis, and collagen deposition due to impaired glucose tolerance.

Research Excerpts

ExcerptRelevanceReference
"Epigallocatechin-3-gallate (EGCG) possesses anti-fibrotic potential in diverse tissues; however, the molecular mechanisms underlying the impacts of EGCG on diabetes-induced myocardial fibrosis remain unclear."8.12Epigallocatechin-3-gallate attenuates myocardial fibrosis in diabetic rats by activating autophagy. ( Jia, Q; Li, Y; Mehmood, S; Yang, R, 2022)
"In order to explore the effects of hydrogen sulfide (H2S) on myocardial fibrosis in diabetic rats and its underlying mechanisms, intraperitoneal injections of streptozotocin were used to establish the diabetes models and sodium hydrosulfide (NaHS) was used as an exogenous donor of H2S."7.81Effects of hydrogen sulfide on myocardial fibrosis in diabetic rats: Changes in matrix metalloproteinases parameters. ( Li, F; Luo, J; Wu, Z; Xiao, T; Yang, J; Zeng, O, 2015)
"Epigallocatechin-3-gallate (EGCG) possesses anti-fibrotic potential in diverse tissues; however, the molecular mechanisms underlying the impacts of EGCG on diabetes-induced myocardial fibrosis remain unclear."4.12Epigallocatechin-3-gallate attenuates myocardial fibrosis in diabetic rats by activating autophagy. ( Jia, Q; Li, Y; Mehmood, S; Yang, R, 2022)
"In order to explore the effects of hydrogen sulfide (H2S) on myocardial fibrosis in diabetic rats and its underlying mechanisms, intraperitoneal injections of streptozotocin were used to establish the diabetes models and sodium hydrosulfide (NaHS) was used as an exogenous donor of H2S."3.81Effects of hydrogen sulfide on myocardial fibrosis in diabetic rats: Changes in matrix metalloproteinases parameters. ( Li, F; Luo, J; Wu, Z; Xiao, T; Yang, J; Zeng, O, 2015)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Jia, Q1
Yang, R1
Mehmood, S1
Li, Y1
Rosa, CM1
Xavier, NP1
Henrique Campos, D1
Fernandes, AA1
Cezar, MD1
Martinez, PF1
Cicogna, AC1
Gimenes, C1
Gimenes, R1
Okoshi, MP1
Okoshi, K1
Xiao, T1
Zeng, O1
Luo, J1
Wu, Z1
Li, F1
Yang, J1
Yang, ZH1
Peng, XD1

Other Studies

4 other studies available for hydroxyproline and Diabetic Cardiomyopathies

ArticleYear
Epigallocatechin-3-gallate attenuates myocardial fibrosis in diabetic rats by activating autophagy.
    Experimental biology and medicine (Maywood, N.J.), 2022, Volume: 247, Issue:17

    Topics: Adenosine; AMP-Activated Protein Kinases; Animals; Autophagy; Beclin-1; Blood Glucose; Catechin; Col

2022
Diabetes mellitus activates fetal gene program and intensifies cardiac remodeling and oxidative stress in aged spontaneously hypertensive rats.
    Cardiovascular diabetology, 2013, Oct-17, Volume: 12

    Topics: Animals; Atrial Natriuretic Factor; Cardiac Myosins; Diabetes Mellitus, Experimental; Diabetic Cardi

2013
Effects of hydrogen sulfide on myocardial fibrosis in diabetic rats: Changes in matrix metalloproteinases parameters.
    Bio-medical materials and engineering, 2015, Volume: 26 Suppl 1

    Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Fibrosis; Heart; Hydrogen Sulfi

2015
Effects of valsartan on diabetic cardiomyopathy in rats with type 2 diabetes mellitus.
    Chinese medical journal, 2010, Volume: 123, Issue:24

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; Collagen Type I; Collagen Type III; Dia

2010